U.S. Markets open in 4 hrs 40 mins

Charts of the Day: Incyte, WD-40, Gain Capital Holdings

Incyte's experimental melanoma treatment fails to meet its phase 3 primary endpoint; WD-40 beat on earnings, missed on revenue and sales growth; Gain Capital Holdings to continue rollout of its cryptocurrency offerings